Your Source for Multiplexed Intracellular and Circulating Cancer Biomarkers
Intracellular cancer biomarkers can clarify the process of oncogenesis, and circulating cancer biomarkers give insight into the body`s response to a tumor and the relationship between a tumor and its environment. Isolated biomarkers, however, are often inadequate to distinguish tumor from non-tumor; multianalyte panels enable measurement of cancer biomarkers simultaneously, illuminating the critical path toward improved diagnosis and therapy.
Multiplex Cancer Biomarker Detection With Our MILLIPLEX MAP Portfolio
Multiplexed detection of both intracellular and circulating cancer biomarkers can accelerate studies of normal homeostasis and tumorigenic processes. Using the Luminex xMAP platform, Millipore`s MILLIPLEX MAP portfolio provides you with the best multiplex tools to meet your research needs: a broad offering of soluble biomarker panels for cancer, inflammation pathways, immune response, and cell metabolism, traditional cell signaling kits and MAPmates, and panels of analytes using the new EpiQuant cell signaling analysis technology.
The Broadest Portfolio of Cancer Research Assays
Millipore offers the broadest portfolio of cancer research antibodies and assays over a variety of platforms, including cell-based assays, ELISAs, flow cytometry, and quantitative cell imaging. Millipore is truly your “one-stop shop” for all your cancer research needs.
|New Product Spotlight|
|Human Circulating Cancer Biomarker Panel 3|
|Get the flexibility you need for your cancer research with our newest Circulating Cancer Biomarker Panel 3 by choosing from 9 circulating cancer biomarkers that can be used to study a wide range of tumor types.|
Biomarkers in the panel include:
New Biomarker Assay for Cancer Research